Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 May 2018 07:00 AM
RNS
California Department of Insurance subpoena
25 May 2018 02:25 PM
RNS
SUBLOCADE(TM) Submitted in Australia for Approval
24 May 2018 07:00 AM
RNS
Indivior Participating in Jefferies NYC Conference
16 May 2018 05:50 PM
RNS
Result of AGM
14 May 2018 07:00 AM
RNS
Indivior settlement with Par Pharmaceutical
10 May 2018 11:40 AM
RNS
Block listing Interim Review
04 May 2018 02:13 PM
RNS
Director/PDMR Shareholding
02 May 2018 07:00 AM
RNS
1st Quarter Results
20 Apr 2018 07:00 AM
RNS
Indivior's SUBLOCADE NDS Accepted by Health Canada
12 Apr 2018 03:56 PM
RNS
Holding(s) in Company
11 Apr 2018 04:02 PM
RNS
Director Declaration
11 Apr 2018 07:00 AM
RNS
Notice of Results
06 Apr 2018 09:31 AM
RNS
Holding(s) in Company
05 Apr 2018 07:00 AM
RNS
Indivior Asserts New SUBOXONE(R) Film Patent
04 Apr 2018 09:28 AM
RNS
Director/PDMR Shareholding
03 Apr 2018 09:33 AM
RNS
Holding(s) in Company
03 Apr 2018 07:00 AM
RNS
Total Voting Rights
29 Mar 2018 07:00 AM
RNS
Indivior and C4X Enter Licensing Agreement
27 Mar 2018 04:13 PM
RNS
Holding(s) in Company
23 Mar 2018 07:00 AM
RNS
Indivior Responds to Court Ruling ANDA litigation
22 Mar 2018 01:39 PM
RNS
Annual Financial Report
13 Mar 2018 03:14 PM
RNS
Director/PDMR Shareholding
12 Mar 2018 04:30 PM
RNS
Director/PDMR Shareholding
02 Mar 2018 02:51 PM
RNS
Holding(s) in Company
02 Mar 2018 10:24 AM
RNS
Holding(s) in Company
01 Mar 2018 01:00 PM
RNS
Indivior Announces SUBLOCADET Available in US
01 Mar 2018 07:00 AM
RNS
Total Voting Rights
28 Feb 2018 05:45 PM
RNS
Director/PDMR Shareholding
28 Feb 2018 04:53 PM
RNS
Holding(s) in Company
19 Feb 2018 07:00 AM
RNS
Holding(s) in Company
15 Feb 2018 07:00 AM
RNS
Final Results
14 Feb 2018 09:50 AM
RNS
Holding(s) in Company
12 Feb 2018 03:49 PM
RNS
Holding(s) in Company
08 Feb 2018 03:27 PM
RNS
Holding(s) in Company
08 Feb 2018 07:00 AM
RNS
Indivior asserts new patent against ANDA-filers
06 Feb 2018 02:14 PM
RNS
Holding(s) in Company
01 Feb 2018 07:05 AM
RNS
Total Voting Rights
01 Feb 2018 07:00 AM
RNS
Indivior Provides Update on Tax Position
19 Jan 2018 07:00 AM
RNS
Notice of Results
08 Jan 2018 09:24 AM
RNS
Holding(s) in Company
04 Jan 2018 01:00 PM
RNS
J.P. Morgan Healthcare Conference
03 Jan 2018 07:00 AM
RNS
Indivior and Addex Enter Strategic Collaboration
19 Dec 2017 07:00 AM
RNS
Indivior amends and extends $534m debt facilities
12 Dec 2017 07:00 AM
RNS
Indivior's RBP-7000 NDA Accepted by FDA
08 Dec 2017 07:00 AM
RNS
Additional Listing
01 Dec 2017 07:00 AM
RNS
FDA Approves SUBLOCADE (TM)
23 Nov 2017 01:46 PM
RNS
Holding(s) in Company
10 Nov 2017 04:02 PM
RNS
Block listing Interim Review
06 Nov 2017 07:00 AM
RNS
Jefferies London Healthcare Conference
02 Nov 2017 01:28 PM
RNS
Board Committee Changes

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100